Works matching DE "VALSARTAN"

Results: 818

Valsartan and Amlodipine Improved Haematological and Biochemical Indices of Vildagliptin-treated Streptozotocin-induced Diabetic Rats.

Published in:

Pharmaceutical & Biomedical Research, 2025, v. 11, n. 2, p. 95, doi. 10.32598/PBR.11.2.671.3

By:

Bolanle, Israel Olapeju;
Erharuyi, Osayemwenre;
Akliigbemen, Abigail M.;
Ugiagbe, Amenaghawon Imuetinyan;
Ekugum, Edobor;
Nwusulor, Samuel O.;
Adudu, Keziah E.;
Falodun, Abiodun

Publication type:

Article

Impact of clinical pharmacy guidance on valsartan recall management: a retrospective review.

Published in:

Drugs & Therapy Perspectives, 2022, v. 38, n. 6, p. 278, doi. 10.1007/s40267-022-00918-6

By:

Sims, Kelli;
Zhu, Winnie;
Zaiken, Kathy

Publication type:

Article

Ball-milled valsartan and its combination with mannitol: the case of drug polyamorphism.

Published in:

Journal of Thermal Analysis & Calorimetry, 2022, v. 147, n. 16, p. 8765, doi. 10.1007/s10973-021-11164-9

By:

Lenschow, Iára Cristina Schmücker;
Bazzo, Giovana Carolina;
Zétola, Melissa;
Stulzer, Hellen Karine;
Soares, Luciano;
Pezzini, Bianca Ramos

Publication type:

Article

Sacubitril/valsartan improves all-cause mortality in heart failure patients with reduced ejection fraction and chronic kidney disease.

Published in:

Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 505, doi. 10.1007/s10557-022-07421-0

By:

Lee, Wei-Chieh;
Liao, Ting-Wei;
Chen, Tien-Yu;
Fang, Hsiu-Yu;
Fang, Yen-Nan;
Chen, Huang-Chung;
Lin, Yu-Sheng;
Chang, Shang-Hung;
Chen, Mien-Cheng

Publication type:

Article

Sacubitril/Valsartan Can Reduce Atrial Fibrillation Recurrence After Catheter Ablation in Patients with Persistent Atrial Fibrillation.

Published in:

Cardiovascular Drugs & Therapy, 2023, v. 37, n. 3, p. 549, doi. 10.1007/s10557-022-07315-1

By:

Wang, Qiqi;
Zhuo, Chengui;
Xia, Qi;
Jiang, Jiajia;
Wu, Bifeng;
Zhou, Dongchen;
Shu, Zheyue;
Zhao, Jianqiang;
Chen, Miao;
Chen, Heng;
Sun, Zewei;
Zhang, Biqi;
Han, Jie;
Zheng, Liangrong

Publication type:

Article

Five Years of Sacubitril/Valsartan—a Safety Analysis of Randomized Clinical Trials and Real-World Pharmacovigilance.

Published in:

Cardiovascular Drugs & Therapy, 2022, v. 36, n. 5, p. 915, doi. 10.1007/s10557-021-07210-1

By:

Kim, Yee Soo;
Brar, Simerjeet;
D'Albo, Natalie;
Dey, Amit;
Shah, Sachin;
Ganatra, Sarju;
Dani, Sourbha S.

Publication type:

Article

Comparison of the Effect of Sacubitril/Valsartan on Left Ventricular Systolic Function in Patients with Non-ischaemic and Ischaemic Cardiomyopathy.

Published in:

Cardiovascular Drugs & Therapy, 2020, v. 34, n. 6, p. 755, doi. 10.1007/s10557-020-07036-3

By:

Ioannou, Adam;
Metaxa, Sofia;
Simon, Steny;
Mandal, Amit K. J.;
Missouris, Constantinos G.

Publication type:

Article

Focus on the Novel Cardiovascular Drug LZC696: from Evidence to Clinical Consideration.

Published in:

Cardiovascular Drugs & Therapy, 2016, v. 30, n. 6, p. 623, doi. 10.1007/s10557-016-6699-5

By:

Lin, L.;
Wu, Y.;
Wu, M.;
Lin, J.

Publication type:

Article

Valsartan Upregulates Kir2.1 in Rats Suffering from Myocardial Infarction via Casein Kinase 2.

Published in:

Cardiovascular Drugs & Therapy, 2015, v. 29, n. 3, p. 209, doi. 10.1007/s10557-015-6598-1

By:

Li, Xinran;
Hu, Hesheng;
Wang, Ye;
Xue, Mei;
Li, Xiaolu;
Cheng, Wenjuan;
Xuan, Yongli;
Yin, Jie;
Yang, Na;
Yan, Suhua

Publication type:

Article

Suppression of Ventricular Arrhythmias After Myocardial Infarction by AT1 Receptor Blockade: Role of the AT2 Receptor and Casein Kinase 2/Kir2.1 Pathway.

Published in:

2015

By:

Jugdutt, Bodh

Publication type:

Editorial

The Role of Casein Kinase 2 in Ion Channel Remodeling After Myocardial Infarction.

Published in:

2015

By:

Kang, Seungwoo

Publication type:

Editorial

Valsartan Attenuates Atherosclerosis via Upregulating the Th2 Immune Response in Prolonged Angiotensin II-Treated ApoE<sup>-/-</sup> Mice.

Published in:

Molecular Medicine, 2015, v. 21, n. 1, p. 143, doi. 10.2119/molmed.2014.00195

By:

Kai Meng;
Qiutang Zeng;
Qinghua Lu;
Yingzhong Lin;
Bangwei Wu;
Kunwu Yu;
Zhaoqiang Dong;
Jianwei Zhang;
Meng Chai;
Yuyang Liu;
Qingwei Ji;
Yujie Zhou

Publication type:

Article

Comparative and Combinatorial Effects of Resveratrol and Sacubitril/Valsartan alongside Valsartan on Cardiac Remodeling and Dysfunction in MI-Induced Rats.

Published in:

Molecules, 2021, v. 26, n. 16, p. 5006, doi. 10.3390/molecules26165006

By:

Raj, Pema;
Sayfee, Karen;
Parikh, Mihir;
Yu, Liping;
Wigle, Jeffrey;
Netticadan, Thomas;
Zieroth, Shelley

Publication type:

Article

Pharmaceutical Composition of Valsartan: β-Cyclodextrin: Physico-Chemical Characterization and Anti-Hypertensive Evaluation.

Published in:

Molecules, 2010, v. 15, n. 6, p. 4067, doi. 10.3390/molecules15064067

By:

de Matos Jensen, Carlos Eduardo;
dos Santos, Robson Augusto Souza;
Leite Denadai, Angelo Márcio;
Ferreira Santos, Cynthia Fernandes;
Gonçalves Braga, Aline Nardoni;
Sinisterra, Rubén Dario

Publication type:

Article

Valsartan Reduced Atrial Fibrillation Susceptibility by Inhibiting Atrial Parasympathetic Remodeling through MAPKs/Neurturin Pathway.

Published in:

Cellular Physiology & Biochemistry (Karger AG), 2015, v. 36, n. 5, p. 2039, doi. 10.1159/000430171

By:

Liu, Lei;
Geng, Jianqiang;
Zhao, Hongwei;
Yun, Fengxiang;
Wang, Xiaoyu;
Yan, Sen;
Ding, Xue;
Li, Wenpeng;
Wang, Dingyu;
Li, Jianqiang;
Pan, Zhenwei;
Gong, Yongtai;
Tan, Xiangyang;
Li, Yue

Publication type:

Article

HEART FAILURE: AN OVERALL ASSESSMENT.

Published in:

2023

By:

Vartela, Vasiliki

Publication type:

Editorial

The power of optimal medical therapy using angiotensin receptor-neprilysin inhibitor in acute decompensated heart failure, sparing a critical patient open-heart surgery with a device therapy: a case report.

Published in:

2021

By:

Gerges, Fady;
Komaranchath, Austin;
Bakshy, Faiz Al;
Almaghraby, Abdallah

Publication type:

Case Study

Evolution of B-type natriuretic peptide and N-terminal pro-brain natriuretic peptide during acute decompensated heart failure in a chronic heart failure patient with reduced ejection fraction treated with Sacubitril/Valsartan: a case report.

Published in:

2019

By:

Tiepolo, Ambre;
Nougué, Hélène;
Damoisel, Charles;
Launay, Jean-Marie;
Vodovar, Nicolas;
Mebazaa, Alexandre

Publication type:

Case Study

Propafenone and valsartan overdose with cardiovascular deterioration managed with lipid emulsion and high dose insulin: a case report.

Published in:

2022

By:

Yoon, Connie H.;
Rine, Natalie I.;
Smith, Adam;
Casavant, Marcel J.

Publication type:

Case Study

Non-extractive spectrophotometric determination of valsartan in pure form and in pharmaceutical products by ion-pair complex formation with bromophenol blue and methyl red.

Published in:

Pharmacia (0428-0296), 2021, v. 68, n. 4, p. 851, doi. 10.3897/pharmacia.68.e73559

By:

Peleshok, Kateryna;
Bondar, Bohdana;
Kryskiw, Liubomyr;
Kucher, Tetyana;
Poliak, Olha;
Logoyda, Liliya

Publication type:

Article

Search for angiotensin II receptor antagonists among 4-aryl-n-(aryl)-3-(prop-2-en-1-yl)-2,3- dihydro-1,3-thiazol-2-imine derivatives.

Published in:

Pharmacia (0428-0296), 2019, v. 66, n. 4, p. 181, doi. 10.3897/pharmacia.66.e36808

By:

Drapak, Iryna;
Zimenkovsky, Borys;
Perekhoda, Lina;
Suleyman, Margarita;
Yeromina, Hanna;
Skaletska, Natalia;
Seredynska, Natalya;
Demchenko, Anatoly

Publication type:

Article

Tolerability and efficacy of sacubitril/valsartan in clinical practice.

Published in:

Internal Medicine Journal, 2021, v. 51, n. 1, p. 87, doi. 10.1111/imj.14749

By:

Nandal, Savvy;
Chow, Chee Loong;
Hannah, Vikki;
Vaddadi, Gautam;
Van Gaal, William

Publication type:

Article

Assessment of statistical power for covariate effects in data from phase I clinical trials.

Published in:

Translational & Clinical Pharmacology, 2015, v. 23, n. 1, p. 31, doi. 10.12793/tcp.2015.23.1.31

By:

Yukyung Kim;
Hankil Son;
Mijeong Son;
Donghwan Lee;
Young-A Heo;
Kyungsoo Park

Publication type:

Article

Refractory Hypotension in a Patient with a History of Anabolic Steroid Abuse Taking an Angiotensin-II Receptor Blocker: A Case Report.

Published in:

AANA Journal, 2017, v. 85, n. 5, p. 340

By:

Jensen, Alyssa B.;
Haas, Richard E.

Publication type:

Article

LIQUID AND SOLID SELF-EMULSIFYING DRUG DELIVERY SYSTEMS (SEDDS) CONTAINING VALSARTAN: STABILITY ASSESSMENT AND PERMEABILITY STUDIES.

Published in:

Journal of Faculty of Pharmacy of Ankara University / Ankara Üniversitesi Eczacilik Fakültesi Dergisi, 2024, v. 48, n. 2, p. 525, doi. 10.33483/jfpau.1385707

By:

YILDIZ TÜRKYILMAZ, Gülbeyaz;
DİRİL, Mine;
GÜLMEZOĞLU, Eda;
KARASULU, Hatice Yeşim

Publication type:

Article

Toward improved predictions of pharmacokinetics of transported drugs in hepatic impairment: Insights from the extended clearance model.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 1, p. 118, doi. 10.1002/psp4.13062

By:

Storelli, Flavia;
Ladumor, Mayur K.;
Liang, Xiaomin;
Lai, Yurong;
Chothe, Paresh P.;
Enogieru, Osatohanmwen J.;
Evers, Raymond;
Unadkat, Jashvant D.

Publication type:

Article

Dodatni učinci fiksne kombinacije amlodipina/valsartana (Wamlox®) i fiksne kombinacije amlodipina/valsartana/hidroklorotiazida (Valtricom®) osim kontrole arterijskog tlaka u bolesnika s arterijskom hipertenzijom 2. ili 3. stupnja – kliničko ispitivanje VICTORY II.

Published in:

Cardiologia Croatica, 2021, v. 16, n. 5/6, p. 223, doi. 10.15836/ccar2021.223

By:

Primožič, Aleša;
Povhe, Alenka Glavač;
Grošelj, Mateja;
Barbič-Žagar, Breda

Publication type:

Article

Early experience with sacubitril/valsartan at University Hospital Centre Zagreb, Department of Cardiovascular Diseases.

Published in:

2017

By:

Pavasović, Saša;
Reschner, Ana;
Pašalić, Marijan;
Miličić, Davor

Publication type:

Abstract

Djelotvornost i sigurnost valsartana i kombinacije valsartana i hidroklorotiazida u liječenju bolesnika s blagom do umjerenom arterijskom hipertenzijom - kliničko ispitivanje VICTORY.

Published in:

Cardiologia Croatica, 2017, v. 12, n. 1/2, p. 28, doi. 10.15836/ccar2017.28

By:

Berkopec, Jure;
Zaletel, Anja;
Vrhunec, Polona Knavs;
Barbič-Žagar, Breda

Publication type:

Article

Effects of sacubitril/valsartan in patients with left ventricular assist devices: Case series.

Published in:

Artificial Organs, 2021, v. 45, n. 2, p. 185, doi. 10.1111/aor.13796

By:

Zorz, Neza;
Frljak, Sabina;
Vrtovec, Bojan

Publication type:

Article

The Effect of an Angiotensin II Antagonist on Hormones of Pituitary-Gonad Axis in Adult Male Rats.

Published in:

Zahedan Journal of Research in Medical Sciences, 2014, v. 16, n. 2, p. 15

By:

Hosseini, S. Ebrahim

Publication type:

Article

Sacubitril/Valsartan vs. Standard Medical Therapy on Exercise Capacity in HFrEF Patients.

Published in:

Life (2075-1729), 2023, v. 13, n. 5, p. 1174, doi. 10.3390/life13051174

By:

Campanile, Alfonso;
Visco, Valeria;
De Carlo, Stefania;
Ferruzzi, Germano Junior;
Mancusi, Costantino;
Izzo, Carmine;
Mongiello, Felice;
Di Pietro, Paola;
Virtuoso, Nicola;
Ravera, Amelia;
Bonadies, Domenico;
Vecchione, Carmine;
Ciccarelli, Michele

Publication type:

Article

Liquid Chromatography Method Development and Optimization for Valsartan: Pharmacokinetics of Oral Hydrogels in Rabbits.

Published in:

Journal of the Chemical Society of Pakistan, 2017, v. 39, n. 6, p. 940

By:

Sohail, Muhammad;
Ahmad, Mahmood;
Minhas, Muhammad Usman;
Munir, Abubakar;
Khalid, Ikrima;
Rashid, Haroon

Publication type:

Article

Treatment of Heart Failure with Sacubitril/Valsartan in Hondurans with Reduced Left Ventricular Ejection Fraction: A Three-Year Experience.

Published in:

International Cardiovascular Research Journal, 2021, v. 15, n. 4, p. 137

By:

Somoza Alvarenga, Francisco Ramón;
Amaya Handal, Ramsés Daniel;
Alas Pineda, César Ulises;
Raudales, Beatriz Mejía;
Martínez, Juan Fernando Toledo;
Trejo, Isaac Gabriel;
Somoza, Francisco José;
Schweinfurth, Ramón Alberto Martínez

Publication type:

Article

Sacubitril/Valsartan: Updates and Clinical Evidence for a Disease-Modifying Approach.

Published in:

Drugs, 2019, v. 79, n. 14, p. 1543, doi. 10.1007/s40265-019-01181-2

By:

Fabris, Enrico;
Merlo, Marco;
Rapezzi, Claudio;
Ferrari, Roberto;
Metra, Marco;
Frigerio, Maria;
Sinagra, Gianfranco

Publication type:

Article

Aliskiren: A Review of its Use as Monotherapy and as Combination Therapy in the Management of Hypertension.

Published in:: Drugs, 2010, v. 70, n. 15, p. 2011, doi. 10.2165/11204360-000000000-00000
Publication type:: Article

Valsartan: More Than a Decade of Experience.

Published in:

Drugs, 2009, v. 69, n. 17, p. 2393, doi. 10.2165/11319460-000000000-00000

By:

Black, Henry R.;
Bailey, Jacqueline;
Zappe, Dion;
Samuel, Rita

Publication type:

Article

First derivative spectrophotometric method for the simultaneous estimation of valsartan and hydrochlorthiazide in their combined dosage form.

Published in:

International Journal of Pharmacy & Life Sciences, 2012, v. 3, n. 7, p. 1828

By:

Patel, Namrata R.;
Patel, Sejal K.

Publication type:

Article

Development and characterization of valsartan and hydrochlorothiazide film coated tablet.

Published in:

International Journal of Pharmacy & Life Sciences, 2011, v. 2, n. 7, p. 963

By:

Pandey, Satyam;
Pandey, Aditya Nath;
singh, Dinesh;
Mishra, Ankit;
Kawadkar, Manisha

Publication type:

Article

Fate of Trace Organic Compounds in Granular Activated Carbon (GAC) Adsorbers for Drinking Water Treatment.

Published in:

Water (20734441), 2017, v. 9, n. 7, p. 479, doi. 10.3390/w9070479

By:

Sperlich, Alexander;
Harder, Mareike;
Zietzschmann, Frederik;
Gnirss, Regina

Publication type:

Article

BOLD MRI to Evaluate the Effects of Sacubitril/Valsartan on Renal Protection in Type 2 Diabetics.

Published in:

Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2025, v. 18, p. 1661, doi. 10.2147/DMSO.S507699

By:

Zhai, Limin;
Wang, Yue;
Xiang, Li;
Ni, Liang-ping;
Zhang, Deyuan;
Pan, Tianrong

Publication type:

Article

Sacubitril/Valsartan Improves Progression of Early Diabetic Nephropathy in Rats Through Inhibition of NLRP3 Inflammasome Pathway.

Published in:

Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2022, v. 15, p. 2479, doi. 10.2147/DMSO.S366518

By:

Pan, Yan;
Liu, Lei;
Yang, Huijuan;
Chen, Weidong;
Chen, Zheng;
Xu, Jing

Publication type:

Article

Validated stability-indicating HPLC-DAD method of analysis for the antihypertensive triple mixture of amlodipine besylate, valsartan and hydrochlorothiazide in their tablets.

Published in:

Arabian Journal of Chemistry, 2017, v. 10, p. S1381, doi. 10.1016/j.arabjc.2013.04.012

By:

Shaalan, Rasha A.;
Belal, Tarek S.;
El Yazbi, Fawzy A.;
Elonsy, Sohila M.

Publication type:

Article

No Improved Patient-Oriented Outcomes With Sacubitril/Valsartan in Adults With Heart Failure and Preserved Ejection Fraction.

Published in:

American Family Physician, 2022, v. 105, n. 6, p. 674C

By:

Slawson, David C.

Publication type:

Article

Comparison of the effects of giving captopril and valsartan in cases of heart failure for people with congenital heart disease.

Published in:

EurAsian Journal of Biosciences, 2020, v. 14, n. 2, p. 3463

By:

Sigit, Marta Lastijani;
Rahman, Mahrus A.;
I. Ketut Alit Utamayasa

Publication type:

Article

CARDIOVASCULAR.

Published in:

2009

By:

Cottrell, Neil

Publication type:

Abstract

N-Nitrosodimethylamine-Contaminated Valsartan and the Risk of Cancer: A Longitudinal Cohort Study Based on German Health Insurance Data.

Published in:

Deutsches Ärzteblatt International, 2021, v. 118, n. 21, p. 357, doi. 10.3238/arztebl.m2021.0129

By:

Gomm, Willy;
Röthlein, Christoph;
Schüssel, Katrin;
Brückner, Gabriela;
Schröder, Helmut;
Heß, Steffen;
Frötschl, Roland;
Broich, Karl;
Haenisch, Britta

Publication type:

Article

Pharmacotherapeutics of sacubitril/valsartan: an overview for nurses.

Published in:

British Journal of Cardiac Nursing, 2025, v. 20, n. 6, p. 1, doi. 10.12968/bjca.2024.0021

By:

Lynch, Micheál;
Hill, Loreena;
Rodgers, Katherine MA

Publication type:

Article

Use of potassium binders to optimise guideline‑driven medical therapy in heart failure: a case study.

Published in:

British Journal of Cardiac Nursing, 2025, v. 20, n. 3, p. 1, doi. 10.12968/bjca.2024.0087

By:

Collier, Louise

Publication type:

Article

NICE: treating symptomatic chronic heart failure with reduced ejection fraction.

Published in:

British Journal of Cardiac Nursing, 2018, v. 13, n. 9, p. 436, doi. 10.12968/bjca.2018.13.9.436

By:

Quaile, Alistair

Publication type:

Article